- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: T-Dxd(Trastuzmab deruxtecan), Ramucirumab
Total 220 results
-
Yonsei UniversityNot yet recruiting
-
Daiichi Sankyo, Inc.AstraZenecaRecruiting
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
National Cancer Center Hospital EastDaiichi Sankyo Co., Ltd.RecruitingGastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaJapan
-
Daiichi SankyoAstraZenecaRecruitingBreast Cancer | Advanced Solid TumorUnited States, Spain, Canada, France
-
AstraZenecaDaiichi Sankyo Co., Ltd.CompletedGastric or Gastroesophageal Junction (GEJ) AdenocarcinomaChina
-
AstraZenecaRecruitingAdvanced Solid MalignanciesUnited States, Korea, Republic of, Spain, Australia, Sweden, Germany, United Kingdom
-
Cancer Trials IrelandRecruitingHER2-positive Breast CancerIreland
-
MedSIRDaiichi Sankyo, Inc.Not yet recruitingBreast Cancer | Metastatic Breast Cancer
-
Daiichi SankyoRecruitingBreast Cancer | Advanced Cancer | HER2-positive Breast Cancer | HER2-low Breast CancerChina
-
Memorial Sloan Kettering Cancer CenterAstraZenecaRecruitingGlioblastoma | Brain Cancer | Metastatic Cancer | Recurrent Glioblastoma | Leptomeningeal MetastasisUnited States
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingMetastatic Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast CancerAustria, Belgium, Italy, Spain, France, Switzerland, Denmark, Norway, Sweden
-
Daiichi SankyoCompletedHER2-positive Breast CancerSpain, Ireland, Italy
-
AstraZenecaDaiichi Sankyo Co., Ltd.RecruitingAdvanced Solid Tumors (Excluding Gastric Cancer and Breast Cancer)China
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingHER2-positive Advanced Gastric Cancer | HER2-positive Gastroesophageal Junction AdenocarcinomaAustria, Belgium, Germany, Italy
-
AstraZenecaDaiichi SankyoActive, not recruitingHER2-mutant Non-Small Cell Lung CancerChina
-
AstraZenecaDaiichi Sankyo Co., Ltd.Active, not recruitingPart 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer | Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal CancerBelgium, United States, Poland, India, Taiwan, Thailand, Korea, Republic of, Czechia, Russian Federation, United Kingdom, Spain, Australia, Canada, Italy, Netherlands
-
Beijing 302 HospitalRecruiting
-
Daiichi SankyoRecruitingAdvanced Solid TumorUnited States
-
Daiichi SankyoAstraZenecaRecruitingMetastatic Cancer | Advanced CancerSpain, Korea, Republic of, Belgium, France, Italy, United States, Australia, Japan, Taiwan, United Kingdom
-
Daiichi Sankyo, Inc.AstraZeneca; NSABP Foundation Inc; German Breast Group; Spanish Breast Cancer Research...Active, not recruitingHER2-Positive Primary Breast Cancer | Residual Invasive Breast CancerUnited States, Spain, France, Germany, Korea, Republic of, United Kingdom, Denmark, Israel, Belgium, Taiwan, Chile, Italy, Japan, Peru, Portugal, China, Turkey, Canada, Ireland, Australia, Greece, Czechia, Singapore, Poland, Romania, Arge... and more
-
AstraZenecaDaiichi SankyoNot yet recruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast CancerCanada
-
AstraZenecaDaiichi Sankyo Co., Ltd.Active, not recruitingAdvanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,BreastItaly, Spain, United States, France, Korea, Republic of, Japan, Canada, Denmark, Belgium
-
Daiichi SankyoAstraZenecaRecruitingGastroesophageal Junction Adenocarcinoma | Gastric Cancer, AdenocarcinomaItaly, Hong Kong, Belgium, Korea, Republic of, France, United Kingdom, Spain, China, Ireland, Brazil, Japan, Singapore, Israel, Russian Federation, Argentina, Chile, Hungary, Poland, Portugal, Taiwan, Turkey, Ukraine, Germany, Romania
-
Enliven TherapeuticsRecruitingHER2-positive Metastatic Breast Cancer | HER2 Gene Mutation | HER2 Mutant Non-small Cell Lung Cancer | HER2 AmplificationUnited States, Spain, Korea, Republic of, Taiwan, Italy, Australia, France
-
Seagen Inc.Active, not recruitingHER2 Positive Breast CancerUnited States
-
Daiichi SankyoAstraZeneca; Daiichi Sankyo Co., Ltd.Active, not recruitingBreast CancerUnited States, Canada, Spain, Belgium, China, Italy, Korea, Republic of, Taiwan, Australia, Japan, Brazil, France, Germany, United Kingdom, Hong Kong
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast Cancer; HER2-positive; MetastaticUnited States, Belgium, Canada, Denmark, Italy, Spain, Hungary, Taiwan, Turkey, France, Germany, Korea, Republic of, Brazil, India, Japan, Peru, Philippines, United Kingdom, China, South Africa, Israel, Russian Federation, Argentina, ... and more
-
Daiichi SankyoMerck Sharp & Dohme LLCRecruitingRecurrent or Metastatic Solid TumorsUnited States
-
Daiichi SankyoAstraZenecaAvailableAdvanced Non-Small Cell Lung Cancer | Metastatic Non Small Cell Lung CancerUnited States
-
QuantumLeap Healthcare CollaborativeRecruitingSolid Tumor | Metastatic Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Solid Tumor, Adult | Solid Carcinoma | HER2-positive Metastatic Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive... and other conditionsUnited States
-
Daiichi Sankyo Co., Ltd.RecruitingAdvanced Solid Tumor | Malignant Solid TumorUnited States, Japan
-
Jeeyun LeeNot yet recruiting
-
AstraZenecaDaiichi SankyoRecruitingLocally Advanced or Metastatic Non-Small Cell Lung CancerChina, Korea, Republic of, United States, Germany, Italy, Poland, Belgium, Mexico, Turkey, Spain, France, Canada, Taiwan, Brazil, Austria, Hong Kong, India, Japan, Netherlands, Denmark
-
AstraZenecaDaiichi SankyoRecruitingLocally Advanced or Metastatic Non-Small Cell Lung CancerKorea, Republic of, Italy, Poland, Malaysia, Taiwan, Thailand, United States, France, Netherlands, Philippines, Canada, Singapore, Spain, Turkey, Australia, Belgium, Israel
-
AstraZenecaDaiichi SankyoActive, not recruitingCarcinoma, Non-Small-Cell Lung | Triple Negative Breast CancerChina
-
Boehringer IngelheimNot yet recruitingMetastatic Breast Cancer | Esophageal Adenocarcinoma | Metastatic Gastric Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma
-
Daiichi SankyoMerck Sharp & Dohme LLCRecruitingMelanoma | Head and Neck Cancer | Gastric Cancer | Advanced Solid TumorJapan
-
Daiichi SankyoMerck Sharp & Dohme LLCRecruitingExtensive-stage Small-cell Lung CancerUnited States, Korea, Republic of, Spain, Taiwan, France, Japan, Germany, China, Austria
-
AstraZenecaDaiichi SankyoCompletedBreast CancerDenmark, Finland, Italy, Norway, Spain, Sweden, Poland, United States, Canada, Germany, Japan, Netherlands, Portugal, Switzerland, Australia, United Kingdom, Belgium, Ireland
-
Sarah Sammons, MDDaiichi SankyoRecruitingBreast Cancer | Breast Cancer Female | Metastatic Triple-Negative Breast Carcinoma | HER2-negative Breast Cancer | HER2 Negative Breast Carcinoma | ER-negative Breast Cancer | ER Positive Breast CancerUnited States
-
MedSIRHoffmann-La RocheNot yet recruiting
-
Fudan UniversityNot yet recruitingTriple-Negative Breast CancerChina
-
Fox Chase Cancer CenterNational Comprehensive Cancer Network; Puma Biotechnology, Inc.RecruitingGastric CancerUnited States
-
Fudan UniversityNot yet recruitingBreast Cancer | Brain Metastases | RadiotherapyChina
-
MedSIRDaiichi SankyoRecruitingMetastatic Breast Cancer | Solid Tumor, Adult | Advanced Non-Small Cell Squamous Lung CancerSpain, Austria
-
AstraZenecaDaiichi Sankyo Company, Limited 3-5-1 Nihonbashihoncho, Chuo-ku, TokyoActive, not recruitingAdvanced or Metastatic Breast CancerUnited States, Belgium, Canada, Denmark, France, Italy, Spain, Hungary, Poland, Taiwan, Russian Federation, Germany, Korea, Republic of, Brazil, Japan, Mexico, United Kingdom, China, Israel, Austria, Australia, Saudi Arabia, Netherl... and more
-
Gustave Roussy, Cancer Campus, Grand ParisDaiichi Sankyo, Inc.RecruitingMetastatic Breast CancerFrance
-
AstraZenecaRecruitingTriple Negative Breast NeoplasmsUnited States, Korea, Republic of, Canada, Taiwan, United Kingdom, Poland
-
Daiichi SankyoAvailableEpidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung CancerUnited States